Nomura Holdings Inc Ultragenyx Pharmaceutical Inc. Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $3.74 Million - $4.93 Million	101,182 Added 44.38%	329,170 $13.2 Million
Q4 2022 Feb 15, 2023	BUY	$33.72 - $46.33 $7.69 Million - $10.6 Million	227,988 New	227,988 $10.6 Million
Q3 2022 Nov 15, 2022	SELL	$39.96 - $66.14 $317,242 - $525,085	-7,939 Reduced 10.18%	70,073 $2.9 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $3.57 Million - $6.66 Million	78,012 New	78,012 $4.89 Million
Q1 2020 May 14, 2020	SELL	$33.8 - $62.9 $222,201 - $413,504	-6,574 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $237,189 - $301,286	6,574 New	6,574 $282,000

325

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.